Remember me
Volume 399, 2026, Pages xiii-xvii
Author links open overlay panelSheila Spada, Lorenzo GalluzziShow moreAccess through your organizationCheck access to the full text by signing in through your organization.
Access through your organizationSection snippetsAcknowledgmentsLG is grateful to the William Guy Forbeck Research Foundation (Carbondale, CO) for fostering the dissemination of knowledge, promoting scientific collaboration and supporting the training of the next generation of leaders in cancer research. LG is/has been supported (as a PI unless otherwise indicated) by one NIH R01 grant (#CA271915), by two Breakthrough Level 2 grants from the US DoD BCRP (#BC180476P1, #BC210945), by a grant from the STARR Cancer Consortium (#I16-0064), by a Transformative
Competing InterestsLG is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, AbbVie, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. SS has no conflicts of interest to declare.
References (31)R. ShandilyaPoint-of-care diagnostics approaches for detection of lung cancer-associated circulating miRNAsDrug Discov Today
(2021)
S. SpadaIsolation of DNA from exosomesMethods Enzymol
(2020)
E. ZhouCirculating extracellular vesicles are effective biomarkers for predicting response to cancer therapyEBioMedicine
(2021)
V. AnagnostouTranslating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapySci Transl Med
(2022)
W.S. AyoubCurrent status of hepatocellular carcinoma detection: screening strategies and novel biomarkersTher Adv Med Oncol
(2019)
L. BakkerusExploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancerOncoimmunology
(2024)
R.C. BastReactivity of a monoclonal antibody with human ovarian carcinomaJ Clin Invest
(1981)
F. BrayGlobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin
(2024)
M.C. CiferriExtracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical ApplicationsBiology (Basel)
(2021)
S.A. CohenPractical recommendations for using ctDNA in clinical decision makingNature
(2023)
S. DalleModulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patientsOncoimmunology
(2024)
S. DasSurface Plasmon Resonance (SPR) Sensor for Cancer Biomarker DetectionBiosensors (Basel)
(2023)
J. FucikovaPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerFront Immunol
(2015)
C. GalassiThe hallmarks of cancer immune evasionCancer Cell
(2024)
A. GangulyEditorial: Spatial immune cell heterogeneity in the tumor microenvironmentFront Immunol
(2024)
View more referencesView full textCopyright © 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Comments (0)